Guardian Pharmacy Services (GRDN) Revenue (2023 - 2026)

Guardian Pharmacy Services has disclosed Revenue across 4 years of filings, most recently posting $336.6 million for Q1 2026.

• Revenue for Q1 2026 came in at $336.6 million, up 2.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 13.54% YoY), and the FY2025 annual result was $1.4 billion, up 17.93% from the prior year.
• Revenue came in at $336.6 million for Q1 2026 at Guardian Pharmacy Services, down from $397.6 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $397.6 million in Q4 2025 to a low of $262.7 million in Q3 2023.
• The 4-year median for Revenue is $329.3 million (2025), against an average of $323.4 million.
• Across the five-year window, Revenue climbed 20.46% in 2024 and grew 2.21% in 2026, its largest moves.
• Guardian Pharmacy Services' Revenue stood at $281.1 million in 2023, then climbed by 20.46% to $338.6 million in 2024, then advanced by 17.44% to $397.6 million in 2025, then fell by 15.35% to $336.6 million in 2026.
• The last three Revenue figures came in at $336.6 million (Q1 2026), $397.6 million (Q4 2025), and $377.4 million (Q3 2025), per Business Quant data.